Suven Pharmaceuticals Ltd.
Snapshot View

436.40 -12.30 ▼-2.7%

23 September 2022, 04:01:00 PM
Volume: 10,373

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.suvenpharm.com
Market Cap 11,109.21 Cr.
Enterprise Value(EV) 11,157.48 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 17.92 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 24.35 Trailing Twelve Months Ending 2022-06
Industry PE 30.97 Trailing Twelve Months Ending 2022-06
Book Value / Share 64.22 Trailing Twelve Months Ending 2022-06
Price to Book Value 6.80 Calculated using Price: 436.40
Dividend Yield 1.15 Period Ending 2022-03
No. of Shares Subscribed 25.46 Cr. 254,564,956 Shares
FaceValue 1
Company Profile
The company is a bio-pharmaceutical company, incorporated with the object of being engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies. Suven Pharma Inc., a Delaware Company, is a WOS (wholly owned subsidiary) of SPL, is a SPV (Special Purpose Vehicle) created on 9th March 2019, for undertaking various business opportunities in Pharma Industry.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-2.74%
1 Week
-5.43%
1 Month
-2.88%
3 Month
-6.71%
6 Month
-25.92%
1 Year
-19.26%
2 Year
+18.69%
5 Year
10 Year
4 years 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 18.92 37.80 30.47 30.48
Return on Capital Employed (%) 23.87 44.55 36.19 43.13
Return on Assets (%) 13.39 25.50 21.52 23.30

Balance Sheet View Details >>

Particulars 4 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 590 845 1,181 1,527
Non Curr. Liab. 35 128 74 92
Curr. Liab. 191 320 322 348
Minority Int.
Equity & Liab. 816 1,292 1,576 1,967
Non Curr. Assets 393 781 910 702
Curr. Assets 423 511 667 1,265
Misc. Exp. not W/O
Total Assets 816 1,292 1,576 1,967

Profit Loss View Details >>

Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 378 834 1,010 1,320 1,395
Other Income 1 18 14 92 98
Total Income 378 852 1,024 1,413 1,493
Total Expenditure -206 -449 -567 -739 -780
PBIDT 172 403 457 674 713
Interest -3 -23 -12 -9 -6
Depreciation -12 -24 -32 -39 -42
Taxation -49 -88 -105 -214 -227
Exceptional Items
PAT 109 269 309 413 439
Minority Interest
Share Associate 48 54 41 17
Other Related Items
Consolidated Net Profit 109 317 362 454 456
Adjusted EPS 12 14 18 18

Cash Flow View Details >>

Particulars 4 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 50 407 383 330
Cash Fr. Inv. -65 -413 -311 -136
Cash Fr. Finan. 26 7 -76 -156
Net Change 11 1 -5 37
Cash & Cash Eqvt 11 12 7 45

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 60.00 60.00 60.00 60.00 60.00 60.00 60.00 60.00 60.00
Public 40.00 40.00 40.00 40.00 40.00 40.00 40.00 40.00 40.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 23 Sep 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that the Company has received intimation from shareholder of the Company regarding loss of share certificate(s) as details mentioned below. A copy of intimation from Shareholder is enclosed herewith.Name of the Holder Folio No. No. of Shares Certificate No.(s) Distinctive Nos. date of receipt of information From To GUMAN MAL JAIN SPC0164189 1000 164189 127242479 127243478 21/09/2022 1000 277064 254529957 254530956 The Company is in process of issuing Letter of Confirmation in lieu of the original share certificate(s) after completion of required formalities.
Wed, 07 Sep 2022
Clarification sought from Suven Pharmaceuticals Ltd
The Exchange has sought clarification from Suven Pharmaceuticals Ltd on September 7 2022 with reference to news appeared inwww.moneycontrol.com dated September 7 2022 quoting "Suven Pharma on the block in talks with PE strategic firms for control deal."

The reply is awaited.
Wed, 07 Sep 2022
Clarification /Confirmation On News Item Appearing In 'Media/Publication'
We refer to your email/letter cited under reference on the subject received through email asking us clarify on the news item that appeared today in the Website-www.moneycontrol.com dated September 07 2022 captioned Suven Pharma on the block in talks with PE strategic firms for control deal.

Technical Scans View Details >>

Fri, 23 Sep 2022
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 6 Months High Decrease 6 Months
CCI Oversold Zone CCI Oversold Zone
MFI Below 20 MFI Below 20

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 220,930.76 920.80 +1.5%
Divi's Laboratories Ltd. 96,681.00 3,641.90 +1.7%
Cipla Ltd. 86,429.87 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. 68,908.63 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. 63,570.07 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. 51,257.56 1,514.50 -1.6%
Max Healthcare Institute Ltd. 41,385.83 426.80 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.80 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-06 31.13 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-06 34.73 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.04 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.96 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 63.99 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-06 65.59 426.80 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.41 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-06 7.78 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-06 4.02 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.40 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.70 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.02 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-06 6.43 426.80 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 0.04 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 426.80 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 426.80 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 426.80 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 426.80 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 426.80 -0.1%

FAQ's On Suven Pharmaceuticals Ltd.

What is Suven Pharma share price?

Can I buy Suven Pharma shares now?

What is the Dividend Yield of Suven Pharma?

What is the Market Cap of Suven Pharma?

What are the key metrics to analyse Suven Pharma?

What is the 52 Week High and Low of Suven Pharma?

What is the trend of Suven Pharma share price?